U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614022) titled 'A Phase I Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive ALL' on May 21.
Brief Summary: The purpose of this research study is to see if a drug called LP-118 is safe and effective for treating adults with Philadelphia chromosome-positive (Ph+) B cell acute lymphoblastic leukemia (ALL), when given with ponatinib, dexamethasone, methotrexate and blinatumomab (the standard treatment for this type of cancer).
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Philadelphia Positive Acute Lymphoblastic Leukemia
Intervention:
DRUG: LP-118...